Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Edgecare Inc. currently has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These 3 pending office actions are distributed among 3 distinct examiners, meaning that each pending application is being reviewed by a different person. This distribution among 3 distinct examiners indicates that the company's current prosecution efforts are spread across multiple individuals at the USPTO.
The 3 pending office actions are split across 2 distinct art units. This distribution across 2 distinct art units suggests that the company's medical and mechanical innovations are being evaluated by 2 different specialized technical groups. IP, JASON M is the busiest examiner for the portfolio, currently managing 1 pending office action. Since there are 3 pending office actions and 3 distinct examiners, the workload is evenly divided. The company must manage its intellectual property by addressing the specific requirements of 2 distinct art units and the individual preferences of 3 different examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IP, JASON M | 1 | 55.2% | +25.2% |
| CELESTINE, NYROBI I | 1 | 81.4% | +23.1% |
| PENG, BO JOSEPH | 1 | 69.5% | +13.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18680545 | BLOOD FLOW MEASURING DEVICE | CELESTINE, NYROBI I | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18436792 | BLADDER VOLUME MEASURING DEVICE | PENG, BO JOSEPH | 67d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18436792 | BLADDER VOLUME MEASURING DEVICE | PENG, BO JOSEPH | 67d overdue |
| 19065127 | Ultrasound device capable of aligning blood vessels and probes for ultrasonic Doppler measurement | IP, JASON M | — |
| 18680545 | BLOOD FLOW MEASURING DEVICE | CELESTINE, NYROBI I | — |
| Art Unit | Apps |
|---|---|
| 3797 | 2 |
| 3798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19065127 | Ultrasound device capable of aligning blood vessels and probes for ultrasonic Doppler measurement | IP, JASON M | 3797 | §103 | Final Rejection | — | Pending | Feb 27, 2025 |
| 18680545 | BLOOD FLOW MEASURING DEVICE | CELESTINE, NYROBI I | 3798 | §103 | Final Rejection | — | Pending | May 31, 2024 |
| 18436792 | BLADDER VOLUME MEASURING DEVICE | PENG, BO JOSEPH | 3797 | §101§112 | Non-Final OA | 67d overdue | Pending | Feb 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial